Also, they signed Scope Australia in Q1, who they've said contributes significantly to headcount, however revenue for this contract doesn't commence until Q2 so wasn't included within the 20% ARR increase for Q1.
There's plenty to look forward to here, especially with the North American sales team recently being setup which we'll start seeing the impact of next year.
IHR Price at posting:
21.0¢ Sentiment: Buy Disclosure: Held
